feed,title,long_url,short_url
Benzinga,"The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data",https://benzinga.com/general/biotech/22/01/25229911/the-daily-biotech-pulse-gileads-blood-cancer-studies-placed-on-partial-clinical-hold-immunocore-g,https://bit.ly/3nV8vhJ
Benzinga,Boeing Clocks 3% Revenue Decline In Q4,https://benzinga.com/news/earnings/22/01/25230869/boeing-clocks-3-revenue-decline-in-q4,https://bit.ly/349JiZG
